Physician profile
Lei Jiang
NPI 1487986949
$1,665.92
in general payments reported to CMS, 2019-2025
27 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $313 · 2022: $512 · 2023: $230 · 2024: $336 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.06 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $134.09 | 2022-2023 | Andexxa, Farxiga |
| Amgen INC. | $120.16 | 2022-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $97.69 | 2021-2024 | Xarelto |
| Phathom Pharmaceuticals, INC. | $92.62 | 2024 | Voquezna |
| Novo Nordisk INC | $80.76 | 2021-2025 | Ozempic, Wegovy |
| Janssen Biotech, INC. | $63.60 | 2024-2025 | Tremfya, Stelara |
| Merck Sharp & Dohme LLC | $58.76 | 2021-2025 | Capvaxive, Gardasil, Gardasil 9 |
| Pfizer INC. | $54.99 | 2022-2025 | |
| Exact Sciences Corporation | $54.54 | 2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $50.69 | 2021-2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $49.36 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.27 | 2024-2025 | |
| Braintree Laboratories, INC. | $45.44 | 2023-2024 | Suflave, Sutab |
| Tactile Systems Technology INC | $26.06 | 2024 | Flexitouch Plus, Entre Plus |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $23.31 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.52 | 2021 | |
| Intercept Pharmaceuticals, INC. | $20.78 | 2023 | Ocaliva |
| Sanofi-Aventis U.S. LLC | $20.11 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $19.31 | 2022 | |
| Lilly USA, LLC | $19.04 | 2022 | |
| Sanofi Pasteur INC. | $18.81 | 2023 | |
| Octapharma USA, INC. | $17.51 | 2025 | Balfaxar |
| Edwards Lifesciences Corporation | $17.14 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Paratek Pharmaceuticals, INC. | $15.57 | 2022 | |
| Neurocrine Biosciences, INC. | $14.46 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.27 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lei Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.